02/18/2025 6:30 PM | Aura Biosciences (Issuer) de los Pinos Elisabet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/18/2025 6:30 PM | Aura Biosciences (Issuer) Hopkins Janet Jill (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/18/2025 6:31 PM | Aura Biosciences (Issuer) Elazzouzi Amy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/18/2025 6:31 PM | Aura Biosciences (Issuer) Plavsic Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/18/2025 6:31 PM | Aura Biosciences (Subject) de los Pinos Elisabet (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025 6:32 PM | Aura Biosciences (Subject) Elazzouzi Amy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025 6:32 PM | Aura Biosciences (Subject) Hopkins Janet Jill (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025 6:32 PM | Aura Biosciences (Subject) Plavsic Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025 10:56 AM | Aura Biosciences (Subject) EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/04/2025 4:51 PM | Aura Biosciences (Issuer) Elazzouzi Amy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 4:51 PM | Aura Biosciences (Issuer) Kilroy Conor (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AURA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aura Biosciences and its competitors with MarketBeat's FREE daily newsletter.
|
02/04/2025 4:51 PM | Aura Biosciences (Issuer) Hopkins Janet Jill (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 4:52 PM | Aura Biosciences (Issuer) Plavsic Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 4:52 PM | Aura Biosciences (Issuer) de los Pinos Elisabet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/21/2025 8:09 PM | Aura Biosciences (Issuer) Elazzouzi Amy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/21/2025 8:09 PM | Aura Biosciences (Issuer) de los Pinos Elisabet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/21/2025 8:10 PM | Aura Biosciences (Subject) Elazzouzi Amy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025 8:10 PM | Aura Biosciences (Subject) de los Pinos Elisabet (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2025 6:20 PM | Aura Biosciences (Subject) Long Focus Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
11/18/2024 8:06 PM | Aura Biosciences (Issuer) Hopkins Janet Jill (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2024 6:32 PM | Aura Biosciences (Subject) Hopkins Janet Jill (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024 4:50 PM | Aura Biosciences (Subject) Lundbeckfond Invest A/S (Filed by)
| Form SC 13G/A | |
11/12/2024 8:32 AM | Adage Capital Management, L.P. (Filed by) Aura Biosciences (Subject)
| Form SC 13G/A | |
10/29/2024 7:33 PM | Aura Biosciences (Subject) Feder Julie B (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024 7:33 PM | Aura Biosciences (Subject) de los Pinos Elisabet (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024 7:38 PM | Aura Biosciences (Subject) Elazzouzi Amy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024 7:23 PM | Aura Biosciences (Issuer) Elazzouzi Amy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 7:28 PM | Aura Biosciences (Issuer) de los Pinos Elisabet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 7:18 PM | Aura Biosciences (Issuer) Elazzouzi Amy (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/22/2024 5:06 PM | Aura Biosciences (Subject) BlackRock, Inc. (Filed by)
| Form SC 13G | |
10/21/2024 5:23 PM | Aura Biosciences (Issuer) Feder Julie B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2024 7:08 PM | Aura Biosciences (Issuer) de los Pinos Elisabet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2024 3:21 PM | Aura Biosciences (Subject) de los Pinos Elisabet (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024 3:21 PM | Aura Biosciences (Subject) Feder Julie B (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024 4:10 PM | Aura Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2024 8:22 PM | Aura Biosciences (Subject) Plavsic Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024 8:25 PM | Aura Biosciences (Issuer) Plavsic Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/01/2024 4:08 PM | Aura Biosciences (Issuer) de los Pinos Elisabet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/27/2024 3:05 PM | Aura Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/12/2024 5:50 AM | Aura Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 6:05 AM | Aura Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Has Trump finally met his match? (Ad) Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again? Click here for his emergency broadcast... |
08/08/2024 6:10 AM | Aura Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/14/2024 3:37 PM | Aura Biosciences (Filer)
| Form 10-K/A | |
06/14/2024 3:42 PM | Aura Biosciences (Filer)
| Form DEFA14A | |
05/09/2024 6:05 AM | Aura Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 6:10 AM | Aura Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/07/2024 11:15 PM | Aura Biosciences (Filer)
| Form EFFECT | |
04/04/2024 3:10 PM | Aura Biosciences (Issuer) Kilroy Conor (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 6:59 AM | Aura Biosciences (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2024 7:12 AM | Aura Biosciences (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/27/2024 6:11 AM | Aura Biosciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/27/2024 6:05 AM | Aura Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/23/2024 3:22 PM | Aura Biosciences (Subject) Rich Cadmus (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |